Cakiroglu, E. Et Al. 2025. Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.. Cell death & disease , vol.16, no.1 , 241.

Cakiroglu, E., Eris, S., Oz, O., Karakülah, G., & Senturk, Ş., (2025). Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.. Cell death & disease , vol.16, no.1, 241.

Cakiroglu, Ece Et Al. "Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.," Cell death & disease , vol.16, no.1, 241, 2025

Cakiroglu, Ece Et Al. "Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.." Cell death & disease , vol.16, no.1, pp.241, 2025

Cakiroglu, E. Et Al. (2025) . "Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.." Cell death & disease , vol.16, no.1, p.241.

@article{article, author={Ece Cakiroglu Et Al. }, title={Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.}, journal={Cell death & disease}, year=2025, pages={241} }